Endogenous Cushing’s Syndrome – FDA Approves Korlym (Mifepristone)



The U.S. Food and Drug Administration has approved Korlym (mifepristone) to control hyperglycemia (high blood sugar levels) in adults with endogenous Cushing’s syndrome, who have type 2 diabetes or glucose intolerance, who remained unresponsive to previous surgery or are not eligible candidates for surgery. Pregnant women should never take Korlym (contraindicated)…

Diabetes news and updates

Source: medicalnewstoday.com

Apps On "Prescription" From Your GP



General practitioners in the UK could soon be “prescribing” cheap or free smartphone apps to help their patients manage their health and medical conditions, according to news released on Wednesday by the Department of Health…

Diabetes news and updates

Source: medicalnewstoday.com

Some Insulin Production Found In Long-Term Type 1 Diabetes





Massachusetts General Hospital (MGH) research has found that insulin production may persist for decades after the onset of type 1 diabetes. Beta cell functioning also appears to be preserved in some patients years after apparent loss of pancreatic function. The study results appear in the March issue of Diabetes Care…

Diabetes news and updates

Source: medicalnewstoday.com

Post under category Diabetes news and update